SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010151
Filing Date
2019-11-06
Accepted
2019-11-06 16:01:15
Documents
51
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20190930x10q.htm 10-Q 1492864
2 EX-31.1 mrns-20190930ex311420710.htm EX-31.1 15202
3 EX-31.2 mrns-20190930ex312a97c09.htm EX-31.2 15377
4 EX-32.1 mrns-20190930ex3212d0c35.htm EX-32.1 9452
5 GRAPHIC mrns20190930x10q001.jpg GRAPHIC 23678
6 GRAPHIC mrns20190930x10q002.jpg GRAPHIC 116855
  Complete submission text file 0001558370-19-010151.txt   4352458

Data Files

Seq Description Document Type Size
7 EX-101.INS mrns-20190930.xml EX-101.INS 719511
8 EX-101.SCH mrns-20190930.xsd EX-101.SCH 25947
9 EX-101.CAL mrns-20190930_cal.xml EX-101.CAL 38563
10 EX-101.DEF mrns-20190930_def.xml EX-101.DEF 87614
11 EX-101.LAB mrns-20190930_lab.xml EX-101.LAB 280762
12 EX-101.PRE mrns-20190930_pre.xml EX-101.PRE 186168
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 191196206
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences